3 results
Approved WMOWill not start
Voor meer informatie verwijs ik u naar sectie 2 in het protocol
Approved WMOCompleted
The goal of the trial is to investigate the safety and efficacy of SAR566658, if it is provided to CA6 protein positive metastaticTBN breastcancer patients.
Approved WMOCompleted
To describe the pharmacokinetic (PK) profile and effectiveness of sarilumab in patients with pcJIA in order to identifythe dose and regimen for continued development in this population.